sitagliptin and its Impurities

Sitagliptin impurity B is also known as Defluoro Sitagliptin, an impurity of Sitagliptan, an dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Reference standards of Sitagliptin API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

Displaying 100 results for sitagliptin Impurities
Drug Reference Standards & Impurity Synthesis in India
PA 19 48000

Sitagliptin

Sitagliptin


  • Catalogue No.:PA 19 48000

  • CAS :

    486460-32-6

  • Molecular Formula : C16H15F6N5O

  • Molecular Weight : 407.31

Drug Reference Standards & Impurity Synthesis in India
PA 19 48010

Sitagliptin Phosphate Monohydrate - Impurity A (Freebase)

Sitagliptin S-Enantiomer


  • Catalogue No.:PA 19 48010

  • CAS :

    823817-55-6

  • Molecular Formula : C16H15F6N5O

  • Molecular Weight : 407.31

Drug Reference Standards & Impurity Synthesis in India
PA 19 48020

Sitagliptin - Impurity B

Sitagliptin Defluoro Impurity


  • Catalogue No.:PA 19 48020

  • CAS :

    486460-31-5

  • Molecular Formula : C16H16F5N5O

  • Molecular Weight : 389.32

Drug Reference Standards & Impurity Synthesis in India
PA 19 48030

Sitagliptin - Impurity C

Sitagliptin 2,4-Difluoro Analogue


  • Catalogue No.:PA 19 48030

  • CAS :

    945261-48-3

  • Molecular Formula : C16H16F5N5O

  • Molecular Weight : 389.32

Drug Reference Standards & Impurity Synthesis in India
PA 19 48510

N-[(2Z)-Piperazin-2-ylidene]-2,2,2-trifluoroacetohydrazide

N-[(2Z)-Piperazin-2-ylidene]-2,2,2-trifluoroacetohydrazide


  • Catalogue No.:PA 19 48510

  • CAS :

    849832-73-1

  • Molecular Formula : C6H9F3N4O

  • Molecular Weight : 210.16

Drug Reference Standards & Impurity Synthesis in India
PA 19 48520

2,2,2-Trifluoro-N'-(pyrazin-2-yl)acetohydrazide

2,2,2-Trifluoro-N'-(pyrazin-2-yl)acetohydrazide


  • Catalogue No.:PA 19 48520

  • CAS :

    837430-15-6

  • Molecular Formula : C6H5F3N4O

  • Molecular Weight : 206.13

Drug Reference Standards & Impurity Synthesis in India
PA 19 48530

3-(Trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyrazine

3-(Trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyrazine


  • Catalogue No.:PA 19 48530

  • CAS :

    486460-20-2

  • Molecular Formula : C6H3F3N4

  • Molecular Weight : 188.11

Drug Reference Standards & Impurity Synthesis in India
PA 19 48540

1-(Pyrazin-2-yl)hydrazine

1-(Pyrazin-2-yl)hydrazine


  • Catalogue No.:PA 19 48540

  • CAS :

    54608-52-5

  • Molecular Formula : C4H6N4

  • Molecular Weight : 110.12

Drug Reference Standards & Impurity Synthesis in India
PA 19 48550

2,2,2-Trifluoro-N'-(2,2,2-trifluoroacetyl)acetohydrazide

2,2,2-Trifluoro-N'-(2,2,2-trifluoroacetyl)acetohydrazide


  • Catalogue No.:PA 19 48550

  • CAS :

    667-35-6

  • Molecular Formula : C4H2F6N2O2

  • Molecular Weight : 224.06

Drug Reference Standards & Impurity Synthesis in India
PA 19 48560

2-(2,3,5-Trifluorophenyl)acetic Acid

2-(2,3,5-Trifluorophenyl)acetic Acid


  • Catalogue No.:PA 19 48560

  • CAS :

    132992-28-0

  • Molecular Formula : C8H5F3O2

  • Molecular Weight : 190.12

Drug Reference Standards & Impurity Synthesis in India
PA 19 48570

Sitagliptin Tablets EP Impurity FP-A

Sitagliptin Tablets EP Impurity FP-A


  • Catalogue No.:PA 19 48570

  • CAS :

    2088771-60-0

  • Molecular Formula : C20H19F6N5O5

  • Molecular Weight : 523.39

Drug Reference Standards & Impurity Synthesis in India
PA 19 48580

Sitagliptin Tablets EP Impurity FP-B

Sitagliptin Tablets EP Impurity FP-B


  • Catalogue No.:PA 19 48580

  • CAS :

    2805078-75-3

  • Molecular Formula : C16H13F6N5O2

  • Molecular Weight : 421.30

Drug Reference Standards & Impurity Synthesis in India
PA 19 48590

Sitagliptin Tablets EP Impurity FP-C

Sitagliptin Tablets EP Impurity FP-C


  • Catalogue No.:PA 19 48590

  • CAS :

    1803026-58-5

  • Molecular Formula : C16H12F6N4O

  • Molecular Weight : 390.28

Drug Reference Standards & Impurity Synthesis in India
PA 19 48600

Sitagliptin Tablets EP Impurity FP-D

Sitagliptin Tablets EP Impurity FP-D


  • Catalogue No.:PA 19 48600

  • CAS :

    1253056-18-6

  • Molecular Formula : C16H12F6N4O

  • Molecular Weight : 390.28

Drug Reference Standards & Impurity Synthesis in India
PA 19 48610

Sitagliptin Tablets EP Impurity FP-E

Sitagliptin Tablets EP Impurity FP-E


  • Catalogue No.:PA 19 48610

  • CAS :

    936630-57-8

  • Molecular Formula : C10H10F3NO2

  • Molecular Weight : 233.19

Drug Reference Standards & Impurity Synthesis in India
PA 19 48620

2,5-Difluorophenylacetic Acid

2,5-Difluorophenylacetic Acid


  • Catalogue No.:PA 19 48620

  • CAS :

    85068-27-5

  • Molecular Formula : C8H6F2O2

  • Molecular Weight : 172.13

Drug Reference Standards & Impurity Synthesis in India
PA 19 48630

3,4-Difluorophenylacetic Acid

3,4-Difluorophenylacetic Acid


  • Catalogue No.:PA 19 48630

  • CAS :

    658-93-5

  • Molecular Formula : C8H6F2O2

  • Molecular Weight : 172.13

Drug Reference Standards & Impurity Synthesis in India
PA 19 48640

2,4-Difluorobenzeneacetic Acid

2,4-Difluorobenzeneacetic Acid


  • Catalogue No.:PA 19 48640

  • CAS :

    81228-09-3

  • Molecular Formula : C8H6F2O2

  • Molecular Weight : 172.13

Drug Reference Standards & Impurity Synthesis in India
PA 19 48650

Sitagliptin Triazole Hydrochloride

Sitagliptin Triazole Hydrochloride


  • Catalogue No.:PA 19 48650

  • CAS :

    762240-92-6

  • Molecular Formula : C6H8ClF3N4

  • Molecular Weight : 228.60

Drug Reference Standards & Impurity Synthesis in India
PA 19 48660

Sitagliptin Enamine Impurity

Sitagliptin Enamine Impurity


  • Catalogue No.:PA 19 48660

  • CAS :

    767340-03-4

  • Molecular Formula : C16H13F6N5O

  • Molecular Weight : 405.3

Drug Reference Standards & Impurity Synthesis in India
PA 19 48670

Sitagliptin Ketoamide Impurity

Sitagliptin Ketoamide Impurity


  • Catalogue No.:PA 19 48670

  • CAS :

    764667-65-4

  • Molecular Formula : C16H12F6N4O2

  • Molecular Weight : 406.28

Drug Reference Standards & Impurity Synthesis in India
PA 19 48680

3-Amino-4-(2,4,5-trifluorophenyl)butanoic Acid Hydrochloride

3-Amino-4-(2,4,5-trifluorophenyl)butanoic Acid Hydrochloride


  • Catalogue No.:PA 19 48680

  • CAS :

    1909337-07-0

  • Molecular Formula : C10H11ClF3NO2

  • Molecular Weight : 269.65

Drug Reference Standards & Impurity Synthesis in India
PA 19 48690

(R)-3-((tert-Butoxycarbonyl)amino)-4-(2,4,5-trifluorophenyl)butanoic Acid

(R)-3-((tert-Butoxycarbonyl)amino)-4-(2,4,5-trifluorophenyl)butanoic Acid


  • Catalogue No.:PA 19 48690

  • CAS :

    486460-00-8

  • Molecular Formula : C15H18F3NO4

  • Molecular Weight : 333.3

Drug Reference Standards & Impurity Synthesis in India
PA 19 48700

(S)-Sitagliptin N-Boc-Acid Impurity

(S)-Sitagliptin N-Boc-Acid Impurity


  • Catalogue No.:PA 19 48700

  • CAS :

    922178-94-7

  • Molecular Formula : C15H18F3NO4

  • Molecular Weight : 333.3

Drug Reference Standards & Impurity Synthesis in India
PA 19 48710

N-Boc-Sitagliptin

N-Boc-Sitagliptin


  • Catalogue No.:PA 19 48710

  • CAS :

    486460-23-5

  • Molecular Formula : C21H23F6N5O3

  • Molecular Weight : 507.43

Drug Reference Standards & Impurity Synthesis in India
PA 19 48720

Trifluoroacetic Acid Hydrazide

Trifluoroacetic Acid Hydrazide


  • Catalogue No.:PA 19 48720

  • CAS :

    1538-08-5

  • Molecular Formula : C2H3F3N2O

  • Molecular Weight : 128.05

Drug Reference Standards & Impurity Synthesis in India
PA 19 48730

1-(Chloroacetyl)-2-(trifluoroacetyl)hydrazine

1-(Chloroacetyl)-2-(trifluoroacetyl)hydrazine


  • Catalogue No.:PA 19 48730

  • CAS :

    762240-99-3

  • Molecular Formula : C4H4ClF3N2O2

  • Molecular Weight : 204.53

Drug Reference Standards & Impurity Synthesis in India
PA 19 48740

(2Z)-1-[5,6-Dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)-2-buten-1-one

(2Z)-1-[5,6-Dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)-2-buten-1-one


  • Catalogue No.:PA 19 48740

  • CAS :

    1803026-54-1

  • Molecular Formula : C16H12F6N4O

  • Molecular Weight : 390.28

Drug Reference Standards & Impurity Synthesis in India
PA 19 48750

2-(3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-7-yl)acetohydrazide

2-(3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-7-yl)acetohydrazide


  • Catalogue No.:PA 19 48750

  • CAS :

    NA

  • Molecular Formula : C9H12F3N5O

  • Molecular Weight : 263.22

Drug Reference Standards & Impurity Synthesis in India
PA 19 48760

2-(3,4,5-Trifluorophenyl)acetic Acid

2-(3,4,5-Trifluorophenyl)acetic Acid


  • Catalogue No.:PA 19 48760

  • CAS :

    209991-62-8

  • Molecular Formula : C8H5F3O2

  • Molecular Weight : 190.12

Drug Reference Standards & Impurity Synthesis in India
PA 19 48770

5-(Trifluoromethyl)-2-(chloromethyl)-1,3,4-oxadiazole

5-(Trifluoromethyl)-2-(chloromethyl)-1,3,4-oxadiazole


  • Catalogue No.:PA 19 48770

  • CAS :

    723286-98-4

  • Molecular Formula : C4H2ClF3N2O

  • Molecular Weight : 186.52

Drug Reference Standards & Impurity Synthesis in India
PA 19 48780

Methyl 3-acetamido-4-(2,4,5-trifluorophenyl)but-2-enoate

Methyl 3-acetamido-4-(2,4,5-trifluorophenyl)but-2-enoate


  • Catalogue No.:PA 19 48780

  • CAS :

    1234321-81-3

  • Molecular Formula : C13H12F3NO3

  • Molecular Weight : 287.23

Drug Reference Standards & Impurity Synthesis in India
PA 19 48790

(3R,3'R)-N,N'-(Ethane-1,2-diyl)bis(3-amino-4-(2,4,5-trifluorophenyl)butanamide)

(3R,3'R)-N,N'-(Ethane-1,2-diyl)bis(3-amino-4-(2,4,5-trifluorophenyl)butanamide)


  • Catalogue No.:PA 19 48790

  • CAS :

    1608491-98-0

  • Molecular Formula : C22H24F6N4O2

  • Molecular Weight : 490.44

Drug Reference Standards & Impurity Synthesis in India
PA 19 48800

3-(Trifluoromethyl)-6,7-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-8(5H)-one

3-(Trifluoromethyl)-6,7-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-8(5H)-one


  • Catalogue No.:PA 19 48800

  • CAS :

    877402-45-4

  • Molecular Formula : C6H5F3N4O

  • Molecular Weight : 206.13

Drug Reference Standards & Impurity Synthesis in India
PA 19 48810

(R,E)-3-Amino-N-(4-oxo-4-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-yl)-4-(2,4,5-trifluorophenyl)but-2-enamide

(R,E)-3-Amino-N-(4-oxo-4-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-yl)-4-(2,4,5-trifluorophenyl)but-2-enamide


  • Catalogue No.:PA 19 48810

  • CAS :

    NA

  • Molecular Formula : C26H21F9N6O2

  • Molecular Weight : 620.47

Drug Reference Standards & Impurity Synthesis in India
PA 19 48820

(R)-3-((tert-Butoxycarbonyl)amino)-4-(2,4-difluorophenyl)butanoic Acid

(R)-3-((tert-Butoxycarbonyl)amino)-4-(2,4-difluorophenyl)butanoic Acid


  • Catalogue No.:PA 19 48820

  • CAS :

    851307-12-5

  • Molecular Formula : C15H19F2NO4

  • Molecular Weight : 315.31

Drug Reference Standards & Impurity Synthesis in India
PA 19 48830

(R)-3-((tert-Butoxycarbonyl)amino)-4-(2,5-difluorophenyl)butanoic Acid

(R)-3-((tert-Butoxycarbonyl)amino)-4-(2,5-difluorophenyl)butanoic Acid


  • Catalogue No.:PA 19 48830

  • CAS :

    486459-98-7

  • Molecular Formula : C15H19F2NO4

  • Molecular Weight : 315.31

Drug Reference Standards & Impurity Synthesis in India
PA 19 48840

(R)-3-((tert-Butoxycarbonyl)amino)-4-(3,4-difluorophenyl)butanoic Acid

(R)-3-((tert-Butoxycarbonyl)amino)-4-(3,4-difluorophenyl)butanoic Acid


  • Catalogue No.:PA 19 48840

  • CAS :

    269396-59-0

  • Molecular Formula : C15H19F2NO4

  • Molecular Weight : 315.31

Drug Reference Standards & Impurity Synthesis in India
PA 19 48850

Boc-D-β-homophenylalanine

Boc-D-β-homophenylalanine


  • Catalogue No.:PA 19 48850

  • CAS :

    101555-61-7

  • Molecular Formula : C15H21NO4

  • Molecular Weight : 279.33

Drug Reference Standards & Impurity Synthesis in India
PA 19 48860

(R)-3-((tert-Butoxycarbonyl)amino)-4-(3-fluorophenyl)butanoic Acid

(R)-3-((tert-Butoxycarbonyl)amino)-4-(3-fluorophenyl)butanoic Acid


  • Catalogue No.:PA 19 48860

  • CAS :

    331763-66-7

  • Molecular Formula : C15H20FNO4

  • Molecular Weight : 297.32

Drug Reference Standards & Impurity Synthesis in India
PA 19 48870

(R)-3-((tert-Butoxycarbonyl)amino)-4-(2-fluorophenyl)butanoic Acid

(R)-3-((tert-Butoxycarbonyl)amino)-4-(2-fluorophenyl)butanoic Acid


  • Catalogue No.:PA 19 48870

  • CAS :

    218608-98-1

  • Molecular Formula : C15H20FNO4

  • Molecular Weight : 297.32

Drug Reference Standards & Impurity Synthesis in India
PA 19 48880

(R)-3-((tert-Butoxycarbonyl)amino)-4-(4-fluorophenyl)butanoic Acid

(R)-3-((tert-Butoxycarbonyl)amino)-4-(4-fluorophenyl)butanoic Acid


  • Catalogue No.:PA 19 48880

  • CAS :

    218609-00-8

  • Molecular Formula : C15H20FNO4

  • Molecular Weight : 297.32

Drug Reference Standards & Impurity Synthesis in India
PA 19 48890

(S)-3-Amino-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butan-1-one (2R,3R)-2,3-bis(benzoyloxy)succinate

(S)-3-Amino-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butan-1-one (2R,3R)-2,3-bis(benzoyloxy)succinate


  • Catalogue No.:PA 19 48890

  • CAS :

    1219440-27-3

  • Molecular Formula : C34H29F6N5O9

  • Molecular Weight : 765.61

Drug Reference Standards & Impurity Synthesis in India
PA 19 57510

3-Amino-4-(2,4,5-trifluorophenyl)butanoic Acid

3-Amino-4-(2,4,5-trifluorophenyl)butanoic Acid


  • Catalogue No.:PA 19 57510

  • CAS :

    1283583-85-6

  • Molecular Formula : C10H10F3NO2

  • Molecular Weight : 233.19

Drug Reference Standards & Impurity Synthesis in India
PA 19 57520

Methyl 3-amino-4-(2,4,5-trifluorophenyl)butanoate

Methyl 3-amino-4-(2,4,5-trifluorophenyl)butanoate


  • Catalogue No.:PA 19 57520

  • CAS :

    1253055-92-3

  • Molecular Formula : C11H12F3NO2

  • Molecular Weight : 247.21

Drug Reference Standards & Impurity Synthesis in India
PA STI 003510

N-Acetyl Sitagliptin-d3

N-Acetyl Sitagliptin-d3


  • Catalogue No.:PA STI 003510

  • CAS :

    1795785-80-6

  • Molecular Formula : C18H13D3F6N5O2

  • Molecular Weight : 452.37

Drug Reference Standards & Impurity Synthesis in India
PA STI 070760

4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl] -1-(2,4,5-trifluorophenyl)butan-2-one-d4

4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl] -1-(2,4,5-trifluorophenyl)butan-2-one-d4


  • Catalogue No.:PA STI 070760

  • CAS :

    NA

  • Molecular Formula : C16H8D4F6N4O2

  • Molecular Weight : 410.31

Drug Reference Standards & Impurity Synthesis in India
PA STI 070770

(2Z)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin -7(8H)-yl]-1-(2,4,5-trifluorophenyl)but-2-en-2-amine-d4

(2Z)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin -7(8H)-yl]-1-(2,4,5-trifluorophenyl)but-2-en-2-amine-d4


  • Catalogue No.:PA STI 070770

  • CAS :

    1620233-76-2

  • Molecular Formula : C16H9D4F6N5O

  • Molecular Weight : 409.32

Drug Reference Standards & Impurity Synthesis in India
PA STI 079340

Sitagliptin-d4 Phosphate

Sitagliptin-d4 Phosphate


  • Catalogue No.:PA STI 079340

  • CAS :

    1432063-88-1

  • Molecular Formula : C16H14D4F6N5O5P

  • Molecular Weight : 509.33

Drug Reference Standards & Impurity Synthesis in India
PA STI 079341

Sitagliptin-d4

Sitagliptin-d4


  • Catalogue No.:PA STI 079341

  • CAS :

    1426173-93-4

  • Molecular Formula : C16H11D4F6N5O

  • Molecular Weight : 411.34

Drug Reference Standards & Impurity Synthesis in India
PA STI 079350

ent-Sitagliptin-d4 Phosphate

ent-Sitagliptin-d4 Phosphate


  • Catalogue No.:PA STI 079350

  • CAS :

    2747914-66-3

  • Molecular Formula : C16H14D4F6N5O5P

  • Molecular Weight : 509.33

Drug Reference Standards & Impurity Synthesis in India
PAI 19 009010

5-(1-Hydroxy-2-(2,4,5-trifluorophenyl)ethylidene)-2,2-dimethyl-1,3-dioxane-4,6-dione

5-(1-Hydroxy-2-(2,4,5-trifluorophenyl)ethylidene)-2,2-dimethyl-1,3-dioxane-4,6-dione


  • Catalogue No.:PAI 19 009010

  • CAS :

    764667-64-3

  • Molecular Formula : C14H11F3O5

  • Molecular Weight : 316.23

Drug Reference Standards & Impurity Synthesis in India
PA 19 48900

(3R)-3-Amino-4-(2,3,6-trifluorophenyl)-1-[3-(trifluoromethyl)-5,6-dihydro[1,2,4] triazolo[4,3-a]pyrazin-7(8H)-yl]butan-1-one

(3R)-3-Amino-4-(2,3,6-trifluorophenyl)-1-[3-(trifluoromethyl)-5,6-dihydro[1,2,4] triazolo[4,3-a]pyrazin-7(8H)-yl]butan-1-one


  • Catalogue No.:PA 19 48900

  • CAS :

    945261-50-7

  • Molecular Formula : C16H15F6N5O

  • Molecular Weight : 407.32

Drug Reference Standards & Impurity Synthesis in India
PA 19 48910

(3R)-3-Amino-4-(3,4-difluorophenyl)-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)butan-1-one

(3R)-3-Amino-4-(3,4-difluorophenyl)-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)butan-1-one


  • Catalogue No.:PA 19 48910

  • CAS :

    486459-88-5

  • Molecular Formula : C16H16F5N5O

  • Molecular Weight : 389.33

Drug Reference Standards & Impurity Synthesis in India
PA 19 48920

2,4,5-Trifluorophenylacetic Acid

2,4,5-Trifluorophenylacetic Acid


  • Catalogue No.:PA 19 48920

  • CAS :

    209995-38-0

  • Molecular Formula : C8H5F3O2

  • Molecular Weight : 190.12

Drug Reference Standards & Impurity Synthesis in India
PA 19 48930

Methyl 3-Oxo-4-(2,4,5-trifluorophenyl)butanoate

Methyl 3-Oxo-4-(2,4,5-trifluorophenyl)butanoate


  • Catalogue No.:PA 19 48930

  • CAS :

    769195-26-8

  • Molecular Formula : C11H9F3O3

  • Molecular Weight : 246.19

Drug Reference Standards & Impurity Synthesis in India
PA 19 48940

2,3,6-Trifluorophenylacetic Acid

2,3,6-Trifluorophenylacetic Acid


  • Catalogue No.:PA 19 48940

  • CAS :

    114152-23-7

  • Molecular Formula : C8H5F3O2

  • Molecular Weight : 190.12

Drug Reference Standards & Impurity Synthesis in India
PA 19 48950

2,4,6-Trifluorophenylacetic Acid

2,4,6-Trifluorophenylacetic Acid


  • Catalogue No.:PA 19 48950

  • CAS :

    209991-63-9

  • Molecular Formula : C8H5F3O2

  • Molecular Weight : 190.12

Drug Reference Standards & Impurity Synthesis in India
PA EPY0001811

Sitagliptin containing impurity A (Y0001811)

Sitagliptin containing impurity A (Y0001811)


  • Catalogue No.:PA EPY0001811

  • CAS :

    NA

  • Molecular Formula : NA

  • Molecular Weight : NA

Drug Reference Standards & Impurity Synthesis in India
PA EPY0001812

Sitagliptin phosphate monohydrate (Y0001812)

Sitagliptin phosphate monohydrate (Y0001812)


  • Catalogue No.:PA EPY0001812

  • CAS :

    NA

  • Molecular Formula : NA

  • Molecular Weight : NA

Drug Reference Standards & Impurity Synthesis in India
PA USP1612903

Sitagliptin Phosphate (1612903)

Sitagliptin Phosphate (1612903)


  • Catalogue No.:PA USP1612903

  • CAS :

    654671-77-9

  • Molecular Formula : NA

  • Molecular Weight : NA

Drug Reference Standards & Impurity Synthesis in India
PA USP1612914

Sitagliptin System Suitability Mixture (Sitagliptin Phosphate containing about 0.2% of S-enantiomer (1612914)

Sitagliptin System Suitability Mixture (Sitagliptin Phosphate containing about 0.2% of S-enantiomer (1612914)


  • Catalogue No.:PA USP1612914

  • CAS :

    NA

  • Molecular Formula : NA

  • Molecular Weight : NA

Drug Reference Standards & Impurity Synthesis in India
PA 19 48515

Sodium 1-(2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-ylidene)-2-(2,4,5-trifluorophenyl)ethan-1-olate

Sodium 1-(2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-ylidene)-2-(2,4,5-trifluorophenyl)ethan-1-olate


  • Catalogue No.:PA 19 48515

  • CAS :

    1253055-91-2

  • Molecular Formula : C14H10F3NaO5

  • Molecular Weight : 338.21

Drug Reference Standards & Impurity Synthesis in India
PA 19 48525

Methyl (S)-3-((tert-butoxycarbonyl)amino)-4-((methylsulfonyl)oxy)butanoate

Methyl (S)-3-((tert-butoxycarbonyl)amino)-4-((methylsulfonyl)oxy)butanoate


  • Catalogue No.:PA 19 48525

  • CAS :

    382638-00-8

  • Molecular Formula : C11H21NO7S

  • Molecular Weight : 311.35

Drug Reference Standards & Impurity Synthesis in India
PA 19 48535

(R)-N-(4-Oxo-4-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-yl)formamide

(R)-N-(4-Oxo-4-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-yl)formamide


  • Catalogue No.:PA 19 48535

  • CAS :

    NA

  • Molecular Formula : C17H15F6N5O2

  • Molecular Weight : 435.33

Drug Reference Standards & Impurity Synthesis in India
PA 19 48960

(R)-7-(3-Amino-4-(2,4,5-trifluorophenyl)butanoyl)-3-(trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine 2-oxide

(R)-7-(3-Amino-4-(2,4,5-trifluorophenyl)butanoyl)-3-(trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine 2-oxide


  • Catalogue No.:PA 19 48960

  • CAS :

    NA

  • Molecular Formula : C16H15F6N5O2

  • Molecular Weight : 423.32

Drug Reference Standards & Impurity Synthesis in India
PA 19 48970

(R)-7-(3-Amino-4-(2,4,5-trifluorophenyl)butanoyl)-3-(trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine 1-oxide

(R)-7-(3-Amino-4-(2,4,5-trifluorophenyl)butanoyl)-3-(trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine 1-oxide


  • Catalogue No.:PA 19 48970

  • CAS :

    NA

  • Molecular Formula : C16H15F6N5O2

  • Molecular Weight : 423.32

Drug Reference Standards & Impurity Synthesis in India
PA 19 48980

Sitagliptin Tablets EP Impurity FP-E (Hydrochloride Salt)

(3R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoic Acid Hydrochloride


  • Catalogue No.:PA 19 48980

  • CAS :

    1204818-19-8

  • Molecular Formula : C10H11ClF3NO2

  • Molecular Weight : 269.65

Drug Reference Standards & Impurity Synthesis in India
PA 19 48990

(R)-Sitagliptin Methyl-Ester Impurity Hydrochloride Salt

(R)-Sitagliptin Methyl-Ester Impurity Hydrochloride Salt


  • Catalogue No.:PA 19 48990

  • CAS :

    1374985-05-3

  • Molecular Formula : C11H13ClF3NO2

  • Molecular Weight : 283.68

Drug Reference Standards & Impurity Synthesis in India
PA 19 48545

1-(2,4,5-Trifluorophenyl)propan-2-amine

1-(2,4,5-Trifluorophenyl)propan-2-amine


  • Catalogue No.:PA 19 48545

  • CAS :

    910409-20-0

  • Molecular Formula : C9H10F3N

  • Molecular Weight : 189.18

Drug Reference Standards & Impurity Synthesis in India
PA 19 48555

7-(3-Amino-4-(2,4,5-trifluorophenyl)butanoyl)-3-(trifluoromethyl)-6,7-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-8(5H)-one

7-(3-Amino-4-(2,4,5-trifluorophenyl)butanoyl)-3-(trifluoromethyl)-6,7-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-8(5H)-one


  • Catalogue No.:PA 19 48555

  • CAS :

    NA

  • Molecular Formula : C16H13F6N5O2

  • Molecular Weight : 421.3

Drug Reference Standards & Impurity Synthesis in India
PA 19 48565

(R)-Sitagliptin Methyl-Ester Impurity

(R)-Sitagliptin Methyl-Ester Impurity


  • Catalogue No.:PA 19 48565

  • CAS :

    881995-69-3

  • Molecular Formula : C11H12F3NO2

  • Molecular Weight : 247.22

Drug Reference Standards & Impurity Synthesis in India
PAI 19 009020

1-[5,6-Dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-3-hydroxy-4-(2,4,5-trifluorophenyl)-1-butanone

1-[5,6-Dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-3-hydroxy-4-(2,4,5-trifluorophenyl)-1-butanone


  • Catalogue No.:PAI 19 009020

  • CAS :

    1253056-01-7

  • Molecular Formula : C16H14F6N4O2

  • Molecular Weight : 408.30

Drug Reference Standards & Impurity Synthesis in India
PA 19 48575

(R)-7-(3-Amino-4-(2,3,5-trifluorophenyl)butanoyl)-3-(trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine 1-Oxide

(R)-7-(3-Amino-4-(2,3,5-trifluorophenyl)butanoyl)-3-(trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine 1-Oxide


  • Catalogue No.:PA 19 48575

  • CAS :

    NA

  • Molecular Formula : C16H15F6N5O2

  • Molecular Weight : 423.32

Drug Reference Standards & Impurity Synthesis in India
PA 19 48585

(R)-3-Amino-N-((R)-4-oxo-4-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,3,5-trifluorophenyl)butan-2-yl)-4-(2,3,5-trifluorophenyl)butanamide

(R)-3-Amino-N-((R)-4-oxo-4-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,3,5-trifluorophenyl)butan-2-yl)-4-(2,3,5-trifluorophenyl)butanamide


  • Catalogue No.:PA 19 48585

  • CAS :

    NA

  • Molecular Formula : C26H23F9N6O2

  • Molecular Weight : 622.5

Drug Reference Standards & Impurity Synthesis in India
PA 19 48595

tert-Butyl (R)-(4-oxo-4-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-yl)carbamate

tert-Butyl (R)-(4-oxo-4-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-yl)carbamate


  • Catalogue No.:PA 19 48595

  • CAS :

    486460-23-5

  • Molecular Formula : C21H23F6N5O3

  • Molecular Weight : 507.44

Drug Reference Standards & Impurity Synthesis in India
PA 19 48605

7-(3-Amino-4-(2,4,5-trifluorophenyl)butanoyl)-3-(trifluoromethyl)-6,7-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-8(5H)-one

7-(3-Amino-4-(2,4,5-trifluorophenyl)butanoyl)-3-(trifluoromethyl)-6,7-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-8(5H)-one


  • Catalogue No.:PA 19 48605

  • CAS :

    NA

  • Molecular Formula : C16H13F6N5O2

  • Molecular Weight : 421.3

Drug Reference Standards & Impurity Synthesis in India
PA 19 48615

N-(4-Oxo-4-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-yl)pivalamide

N-(4-Oxo-4-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-yl)pivalamide


  • Catalogue No.:PA 19 48615

  • CAS :

    1351498-33-3

  • Molecular Formula : C21H23F6N5O2

  • Molecular Weight : 491.44

Drug Reference Standards & Impurity Synthesis in India
PA 19 48625

3-Amino-N-(4-oxo-4-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-yl)-4-(2,4,5-trifluorophenyl)butanamide

3-Amino-N-(4-oxo-4-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-yl)-4-(2,4,5-trifluorophenyl)butanamide


  • Catalogue No.:PA 19 48625

  • CAS :

    NA

  • Molecular Formula : C26H23F9N6O2

  • Molecular Weight : 622.5

Drug Reference Standards & Impurity Synthesis in India
PA 19 48635

3-Amino-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butan-1-one

3-Amino-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butan-1-one


  • Catalogue No.:PA 19 48635

  • CAS :

    NA

  • Molecular Formula : C16H15F6N5O

  • Molecular Weight : 407.32

Drug Reference Standards & Impurity Synthesis in India
PA 19 57530

3-Amino-4-(2,5-difluorophenyl)-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)butan-1-one Phosphate Hydrate

3-Amino-4-(2,5-difluorophenyl)-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)butan-1-one Phosphate Hydrate


  • Catalogue No.:PA 19 57530

  • CAS :

    NA

  • Molecular Formula : C16H21F5N5O6P

  • Molecular Weight : 505.34

Drug Reference Standards & Impurity Synthesis in India
PA 19 57540

3-Amino-4-(2,4-difluorophenyl)-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)butan-1-one Phosphate Hydrate

3-Amino-4-(2,4-difluorophenyl)-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)butan-1-one Phosphate Hydrate


  • Catalogue No.:PA 19 57540

  • CAS :

    NA

  • Molecular Formula : C16H21F5N5O6P

  • Molecular Weight : 505.34

Drug Reference Standards & Impurity Synthesis in India
PA 19 57550

3-Amino-4-(3,4-difluorophenyl)-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)butan-1-one Phosphate Hydrate

3-Amino-4-(3,4-difluorophenyl)-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)butan-1-one Phosphate Hydrate


  • Catalogue No.:PA 19 57550

  • CAS :

    NA

  • Molecular Formula : C16H21F5N5O6P

  • Molecular Weight : 505.34

Drug Reference Standards & Impurity Synthesis in India
PA 19 0481000

(R)-10-(2,4,5-Trifluorobenzyl)-3-(trifluoromethyl)-6,7,10,11-tetrahydro-[1,2,4]triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione

(R)-10-(2,4,5-Trifluorobenzyl)-3-(trifluoromethyl)-6,7,10,11-tetrahydro-[1,2,4]triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione


  • Catalogue No.:PA 19 0481000

  • CAS :

    2088771-61-1

  • Molecular Formula : C16H13F6N5O2

  • Molecular Weight : 421.3

Drug Reference Standards & Impurity Synthesis in India
PA 19 0481001

N,N'-(Ethane-1,2-diyl)bis(3-amino-4-(2,4,5-trifluorophenyl)butanamide) Dihydrochloride

N,N'-(Ethane-1,2-diyl)bis(3-amino-4-(2,4,5-trifluorophenyl)butanamide) Dihydrochloride


  • Catalogue No.:PA 19 0481001

  • CAS :

    NA

  • Molecular Formula : C22H26Cl2F6N4O2

  • Molecular Weight : 563.37

Drug Reference Standards & Impurity Synthesis in India
PA 19 0481002

10-(2,4,5-Trifluorobenzyl)-3-(trifluoromethyl)-6,7,10,11-tetrahydro-[1,2,4]triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione

10-(2,4,5-Trifluorobenzyl)-3-(trifluoromethyl)-6,7,10,11-tetrahydro-[1,2,4]triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione


  • Catalogue No.:PA 19 0481002

  • CAS :

    2805078-75-3

  • Molecular Formula : C16H13F6N5O2

  • Molecular Weight : 421.3

Drug Reference Standards & Impurity Synthesis in India
PA 19 0481003

2,3,4-Trifluorophenylacetic Acid

2,3,4-Trifluorophenylacetic Acid


  • Catalogue No.:PA 19 0481003

  • CAS :

    243666-12-8

  • Molecular Formula : C8H5F3O2

  • Molecular Weight : 190.12

Drug Reference Standards & Impurity Synthesis in India
PA 19 0481005

Rac-Sitagliptin

Rac-Sitagliptin


  • Catalogue No.:PA 19 0481005

  • CAS :

    823817-56-7

  • Molecular Formula : C16H15F6N5O

  • Molecular Weight : 407.32

Drug Reference Standards & Impurity Synthesis in India
PA 19 0481004

3,3'-Oxybis(1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butan-1-one)

3,3'-Oxybis(1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butan-1-one)


  • Catalogue No.:PA 19 0481004

  • CAS :

    NA

  • Molecular Formula : C32H26F12N8O3

  • Molecular Weight : 798.59

Drug Reference Standards & Impurity Synthesis in India
PA 19 0481006

Sitagliptin System Suitability Mixture

Sitagliptin System Suitability Mixture


  • Catalogue No.:PA 19 0481006

  • CAS :

    NA

  • Molecular Formula : C16H18F6N5O5P

  • Molecular Weight : 505.31

Drug Reference Standards & Impurity Synthesis in India
PA 19 0481007

1-(3-(Trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)but-3-en-1-one

1-(3-(Trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)but-3-en-1-one


  • Catalogue No.:PA 19 0481007

  • CAS :

    1675201-14-5

  • Molecular Formula : C16H12F6N4O

  • Molecular Weight : 390.29

Drug Reference Standards & Impurity Synthesis in India
PA 19 0481008

(R)-N-(4-Oxo-4-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-yl)acetamide

(R)-N-(4-Oxo-4-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-yl)acetamide


  • Catalogue No.:PA 19 0481008

  • CAS :

    1379666-94-0

  • Molecular Formula : C18H17F6N5O2

  • Molecular Weight : 449.36

Drug Reference Standards & Impurity Synthesis in India
PA 19 0481009

Methyl (R)-3-((tert-butoxycarbonyl)amino)-4-(2,4,5-trifluorophenyl)butanoate

Methyl (R)-3-((tert-butoxycarbonyl)amino)-4-(2,4,5-trifluorophenyl)butanoate


  • Catalogue No.:PA 19 0481009

  • CAS :

    881995-73-9

  • Molecular Formula : C16H20F3NO4

  • Molecular Weight : 347.33

Drug Reference Standards & Impurity Synthesis in India
PA 19 0481010

(S)-2-(((R)-4-Oxo-4-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-yl)amino)-2-phenylacetamide

(S)-2-(((R)-4-Oxo-4-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-yl)amino)-2-phenylacetamide


  • Catalogue No.:PA 19 0481010

  • CAS :

    769195-20-2

  • Molecular Formula : C24H22F6N6O2

  • Molecular Weight : 540.47

Drug Reference Standards & Impurity Synthesis in India
PA 19 0481011

(R)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-phenylbutan-2-amine

(R)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-phenylbutan-2-amine


  • Catalogue No.:PA 19 0481011

  • CAS :

    NA

  • Molecular Formula : C16H18F3N5O

  • Molecular Weight : 353.35

Drug Reference Standards & Impurity Synthesis in India
PA 19 0481012

(R)-(4-Oxo-4-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-yl)sulfamic acid

(R)-(4-Oxo-4-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-yl)sulfamic acid


  • Catalogue No.:PA 19 0481012

  • CAS :

    940002-57-3

  • Molecular Formula : C16H15F6N5O4

  • Molecular Weight : 487.38

Drug Reference Standards & Impurity Synthesis in India
PA 19 0481013

(2S,3S,4S,5R,6S)-3,4,5-Trihydroxy-6-[[(2R)-4-oxo-4-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-1-(2,4,5-trifluorophenyl)butan-2-yl]carbamoyloxy]oxane-2-carboxylic Acid

(2S,3S,4S,5R,6S)-3,4,5-Trihydroxy-6-[[(2R)-4-oxo-4-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-1-(2,4,5-trifluorophenyl)butan-2-yl]carbamoyloxy]oxane-2-carboxylic Acid


  • Catalogue No.:PA 19 0481013

  • CAS :

    940002-59-5

  • Molecular Formula : C23H23F6N5O9

  • Molecular Weight : 627.45

Drug Reference Standards & Impurity Synthesis in India
PA 19 0481015

(3R)-3-Amino-1-(3-methyl-5,6,8,8a-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazin-7(3H)-yl)-4-(2,4,5-trifluorophenyl)butan-1-one

(3R)-3-Amino-1-(3-methyl-5,6,8,8a-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazin-7(3H)-yl)-4-(2,4,5-trifluorophenyl)butan-1-one


  • Catalogue No.:PA 19 0481015

  • CAS :

    NA

  • Molecular Formula : C16H20F3N5O

  • Molecular Weight : 355.37

Drug Reference Standards & Impurity Synthesis in India
PA 19 0481016

3-((Tert-butoxycarbonyl)amino)-4-(2,5-difluorophenyl)butanoic acid

3-((Tert-butoxycarbonyl)amino)-4-(2,5-difluorophenyl)butanoic acid


  • Catalogue No.:PA 19 0481016

  • CAS :

    1271773-97-7

  • Molecular Formula : C15H19F2NO4

  • Molecular Weight : 315.32

Drug Reference Standards & Impurity Synthesis in India
PA 19 0481017

(Z)-N-(4-Oxo-4-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)but-2-en-2-yl)acetamide

(Z)-N-(4-Oxo-4-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)but-2-en-2-yl)acetamide


  • Catalogue No.:PA 19 0481017

  • CAS :

    NA

  • Molecular Formula : C18H15F6N5O2

  • Molecular Weight : 447.34

pharmaffiliates